• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    11/15/24 4:33:49 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples
    Get the next $LWAY alert in real time by email
    SC 13D/A 1 d860643dsc13da.htm SC 13D/A SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 6)*

     

     

    LIFEWAY FOODS, INC.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    531914109

    (CUSIP Number)

     

    Samantha Loh

    Danone S.A.

    17 boulevard Haussmann

    75009 Paris, France

    Tel: +33 1 44 35 20 20

     

    Nancy Dowling

    Danone North America PBC

    1 Maple Avenue

    White Plains, NY 10605

    Tel: (914) 872 8400

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

     

    With copies to:

    Joshua R. Cammaker

    Wachtell, Lipton, Rosen & Katz

    51 W 52nd St, New York, NY 10019

    Tel: (212) 403 1000

    November 15, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: ☐

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 531914109

     

     1   

     NAMES OF REPORTING PERSONS

     

     Danone S.A.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     WC

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     France

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSONS

    WITH

     

        7    

     SOLE VOTING POWER

     

     0

        8   

     SHARED VOTING POWER

     

     3,454,756

        9   

     SOLE DISPOSITIVE POWER

     

     0

       10   

     SHARED DISPOSITIVE POWER

     

     3,454,756

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     3,454,756

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     23.3%(1)

    14  

     TYPE OF REPORTING PERSON

     

     CO


    CUSIP No. 531914109

     

     1   

     NAMES OF REPORTING PERSONS

     

     Danone North America PBC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     SOURCE OF FUNDS

     

     WC

     5  

     CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

     

     ☐

     6  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSONS

    WITH

     

        7    

     SOLE VOTING POWER

     

     3,454,756

        8   

     SHARED VOTING POWER

     

     0

        9   

     SOLE DISPOSITIVE POWER

     

     3,454,756

       10   

     SHARED DISPOSITIVE POWER

     

     0

    11   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     3,454,756

    12  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

     ☐

    13  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

     23.3%(1)

    14  

     TYPE OF REPORTING PERSON

     

     CO

     

    (1)

    Percentages calculated on the basis of 14,816,470 shares of the Issuer’s common stock, no par value, outstanding as of November 6, 2024, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024 filed with the Securities and Exchange Commission on November 14, 2024, and rounded off to the nearest tenth in accordance with instruction 13 of the cover page for Schedule 13D.


    Introductory Note

    This Amendment No. 6 to Schedule 13D relates to the common stock, no par value (the “Common Stock”), of Lifeway Foods, Inc., an Illinois corporation (the “Issuer”), and amends the Schedule 13D filed on October 12, 1999 (the “Initial Filing”), as amended by Amendment No. 1 to Schedule 13D filed on October 29, 1999, Amendment No. 2 to Schedule 13D filed on November 10, 1999, Amendment No. 3 to Schedule 13D filed on January 5, 2000, Amendment No. 4 to Schedule 13D filed on September 23, 2024, and Amendment No. 5 to Schedule 13D filed on November 15, 2024 (the Initial Filing together with Amendments Nos. 1-5, the “Original Schedule 13D”).

    This Amendment No. 6 is being filed to amend the Original Schedule 13D as follows:

    Item 4. Purpose of Transaction.

    Item 4 of the Original Schedule 13D is hereby amended and supplemented to add the following:

    As reported in prior amendments to the Original Schedule 13D, on September 23, 2024, Danone North America PBC sent a letter to the Issuer (the “Initial Proposal”) proposing to acquire all of the outstanding shares of Common Stock not currently held by the Reporting Persons (the “Proposed Transaction”). On November 5, 2024, the Issuer issued a press release announcing that the Issuer rejected the Initial Proposal and that the Issuer had adopted a shareholder rights plan in response to the Initial Proposal. On November 15, 2024, the Reporting Persons sent a letter to the Issuer (the “Updated Proposal”) increasing the proposed purchase price in the Proposed Transaction to $27.00 per share in cash.

    Subsequent to the Issuer rejecting the Initial Proposal and prior to the submission of the Updated Proposal, on November 8, 2024, Sidley Austin LLP, counsel to the Board of the Issuer, sent a letter on behalf of the Board of the Issuer to counsel to the Reporting Persons (the “Sidley Austin Letter”). The Sidley Austin Letter states that it is being sent in connection with the Initial Proposal and alleges that the Stockholders’ Agreement to which Danone North America PBC (formerly known as Danone Foods, Inc.), the Issuer and members of the Smolyansky family have been party to since 1999 (the “Shareholder Agreement”) is invalid. The Sidley Austin Letter indicates that the Issuer is willing to forgo litigation over the Shareholder Agreement if Danone North America PBC agrees to waive all its rights under, and not seek to enforce any of its rights under, the Shareholder Agreement by 5:00 pm Eastern Time on November 15, 2024. On the same date, Julie Smolyansky, the Chairperson and CEO of the Issuer, sent another letter to the Reporting Persons in which, among other things, she criticized the Shareholder Agreement and asserted that the Shareholder Agreement is invalid.

    On November 15, 2024, counsel to the Reporting Persons responded to the Sidley Austin Letter (the “Danone Response Letter”), disagreeing with the contentions in the Sidley Austin Letter and providing support for the fact that the Shareholder Agreement is valid and enforceable. The Danone Response Letter confirms that the Reporting Persons waive none of their rights under the Shareholder Agreement, and demands that the Issuer (and Ms. Smolyansky, who is also party to the Shareholder Agreement) comply with their respective longstanding, legally required obligations. The foregoing summary of the Danone Response Letter is not intended to be complete and is qualified in its entirety by reference to the full text of the Danone Response Letter, which is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

    The Reporting Persons intend to vigorously defend against the claims set forth in the Sidley Austin Letter and any related claims, if any such claims are asserted, and to continue to assert and enforce their rights under the Shareholder Agreement. The Reporting Persons may in the future take any actions in connection therewith that they deem appropriate. 

    Item 7. Material to be Filed as Exhibits.

     

    Exhibit
    Number
      

    Description

    99.1    Letter from Danone’s Counsel to the Issuer’s Counsel, dated as of November 15, 2024


    SIGNATURE

    After reasonable inquiry and to the best of our knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    November 15, 2024

     

    DANONE S.A.
    By:  

    /s/ Christine Flamand

    Name: Christine Flamand
    Title: General Counsel
    DANONE NORTH AMERICA PBC
    By:  

    /s/ Shane Grant

    Name: Shane Grant
    Title: President and Chief Executive Officer
    Get the next $LWAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LWAY

    DatePrice TargetRatingAnalyst
    9/24/2024Outperform → Market Perform
    Noble Capital Markets
    5/30/2024$20.00Market Perform → Outperform
    Noble Capital Markets
    4/5/2024$25.00Buy
    Lake Street
    3/27/2024Outperform → Market Perform
    Noble Capital Markets
    2/26/2024$14.00Market Perform → Outperform
    Noble Capital Markets
    11/27/2023Outperform → Market Perform
    Noble Capital Markets
    11/14/2023$13.00Market Perform → Outperform
    Noble Capital Markets
    9/25/2023Outperform → Market Perform
    Noble Capital Markets
    More analyst ratings

    $LWAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      11/15/24 4:33:49 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      11/15/24 8:53:57 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      9/23/24 4:07:26 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Financials

    Live finance-specific insights

    See more
    • Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

      Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme

      5/13/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Record Week Surpassing $5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

      Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con

      4/29/25 6:45:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2024 Results

      Company achieves 2024 net sales of $186.8 million; up 17% year-over-year 21st consecutive quarter of year-over-year growth Growing consumer interest in probiotic foods with bioavailable nutrients continues to drive strong demand for Lifeway products MORTON GROVE, Ill., March 14, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the fourth quarter and full year ended December 31, 2024. "I am pleased to report another reco

      3/14/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    SEC Filings

    See more
    • SEC Form 10-Q filed by Lifeway Foods Inc.

      10-Q - Lifeway Foods, Inc. (0000814586) (Filer)

      5/13/25 9:00:23 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Lifeway Foods, Inc. (0000814586) (Filer)

      4/29/25 6:46:02 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form 10-K/A filed by Lifeway Foods Inc.

      10-K/A - Lifeway Foods, Inc. (0000814586) (Filer)

      4/29/25 4:15:08 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO, President and Secretary Smolyansky Julie sold $1,103,500 worth of shares (50,000 units at $22.07), decreasing direct ownership by 2% to 2,132,483 units (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/20/25 3:12:39 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Member of 10% owner group Smolyansky Ludmila sold $891,927 worth of shares (37,482 units at $23.80) (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/5/25 4:50:03 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Member of 10% owner group Smolyansky Ludmila sold $487,769 worth of shares (20,518 units at $23.77) (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/1/25 5:01:56 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

      Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme

      5/13/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Edward Smolyansky Rebukes Lifeway Foods (NASDAQ: LWAY) 2024 Amended 10-K Filing

      CHICAGO, May 2, 2025 /PRNewswire/ -- Edward Smolyansky, who together with Ludmila Smolyansky, beneficially own approximately 27% of outstanding shares of Lifeway Foods common stock, today issued the following statement in response to Lifeway's amended 2024 Annual Report and its latest disclosures on executive and director compensation. Apparent Delay of 2025 Annual Meeting of Shareholders On March 13, Edward Smolyansky submitted a full slate of Board nominees for Lifeway's 2025 Annual Meeting. To date, Lifeway has yet to file a preliminary or definitive proxy statement setting forth its own slate. "The filing of the amended 2024 Annual Report, and other steps taken recently by the Company,

      5/2/25 12:50:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Record Week Surpassing $5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

      Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con

      4/29/25 6:45:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lifeway Foods downgraded by Noble Capital Markets

      Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform

      9/24/24 8:32:49 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods upgraded by Noble Capital Markets with a new price target

      Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00

      5/30/24 9:15:56 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lake Street initiated coverage on Lifeway Foods with a new price target

      Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00

      4/5/24 8:42:53 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples